pharmaphorum
JUNE 10, 2025
Discover how statistical methodologies are transforming drug development by leveraging real-world evidence (RWE) to improve decision-making and outcomes. Explore the impact and benefits of utilising RWE in pharmaceutical research.
STAT
JUNE 12, 2025
When House Republicans voted in the wee hours of the morning of May 22 to cut approximately $700 billion from Medicaid , they moved one step closer to rendering dangerously vulnerable the millions of Medicaid recipients struggling with mental illness and substance use disorder. Medicaid, which covers more than 72 million Americans, is the single largest payer of behavioral health services , which includes mental health and substance use disorder treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JUNE 9, 2025
Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
Express Pharma
JUNE 8, 2025
According to the GlobalData report, the global pharma industry reported 76 mergers and acquisitions (M&A) deals in May 2025, amounting to a total disclosed value of $6.96 billion. This figure marks a decline compared to the previous 12-month average from May 2024 to April 2025, which recorded 95 deals worth $12.4 billion. According to industry data, three major transactions contributed 59 per cent of the total deal value in May.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharmafile
JUNE 10, 2025
Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab. The data was presented at the European Renal Association Congress on 6 June 2025 […] The post Takeda presents positive results from trial of chronic kidney disease treatment appeared first on Pharmafi
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmaceutical Technology
JUNE 13, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
PharmaVoice
JUNE 10, 2025
Ronny Gal, chief strategy and growth officer at Novartis, is guiding the company into a new era shaped by science-minded M&A and a slimmed-down pivot.
NY Times
JUNE 10, 2025
Pharmacy benefit managers have used anti-competitive practices to dominate the prescription drug market.
STAT
JUNE 11, 2025
In December 2023, a groundbreaking announcement grabbed headlines : After years of anticipation, the Food and Drug Administration approved the first gene therapies for treating sickle cell disease, offering hope of eliminating life-altering symptoms. News at the time also featured the treatment’s prohibitive cost — between $2 and $3 million per person.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Pharmacist
JUNE 10, 2025
Community pharmacists, pharmacy technicians, their spouses or children could benefit from up to £5,000 in university educational grants and bursaries from a charity. Independent education charity, Leverhulme Trade Charities Trust (LTCT), provides financial aid for those working in the pharmacy, convenience, grocery trades and is offering £3,000 a year for undergraduate and £5,000 a year […] The post Pharmacists can apply for educational funding for their family appeared first on The Pharma
Med Ed 101
JUNE 8, 2025
Angiotensin II receptor blockers (ARBs) are widely used in managing hypertension, heart failure, chronic kidney disease (CKD), and diabetic nephropathy. While these agents share a common mechanism—blocking the angiotensin II type 1 (AT₁) receptor—not all ARBs are created equal. As healthcare professionals, understanding the nuanced differences can guide therapy optimization, especially in patients with comorbidities […] The post Losartan Differences – A Deep Dive on ARBs appeared fir
PharmaTech
JUNE 10, 2025
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
STAT
JUNE 11, 2025
For more than a half-century, the Centers for Disease Control and Prevention has relied on outside experts to guide the agency’s recommendations on how vaccines should be used to prevent the spread of infectious disease. That task will now fall to a panel that includes several individuals who’ve either been openly critical of vaccines or who have scant infectious disease expertise.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
JUNE 10, 2025
MSD could soon enter the US market for drugs used to protect infants from RSV infections, setting up a rivalry with AstraZeneca/Sanofi's Beyfortus
Pharmaceutical Business Review
JUNE 9, 2025
Duvyzat must be administered alongside corticosteroids and is not limited by the patient’s specific genetic mutation. The decision is applicable across all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. Following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in April 2025, this approval marks a significant milestone.
The Pharmacist
JUNE 9, 2025
Access to ear and hearing healthcare is becoming increasingly challenging. According to RNID, four in ten patients wait longer than six weeks on average for an audiology assessment. In addition, the postcode lottery of wax removal services in the UK is leading to dangerous self-management. Hearing loss is far more than just a minor inconvenience […] The post Pharmacists are well placed to take the lead on ear health appeared first on The Pharmacist.
STAT
JUNE 10, 2025
We recently went viral. Well, not exactly us — but people like us. We are participants in the Yale LISTEN Study , a patient-centered study to better understand long Covid and the adverse effects some patients have experienced post Covid-vaccination. We are members of the post-vaccination cohort, a group that includes more than 250 patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Marketing Network
JUNE 13, 2025
By Max Kopp Diabetes care is entering a new era—yet even in 2025, continuous glucose monitors (CGMs) remain out of reach for millions. Despite a decade of innovation, current CGMs often fail to meet the needs of everyday people with type 2 diabetes, particularly those in under-resourced or underserved communities. High costs, skin invasiveness, and insurance limitations act as real barriers, not just for adoption, but for long-term engagement.
NY Times
JUNE 11, 2025
Skip to content Skip to site index Today’s Paper Opinion | It’s Code Red for Vaccines [link] Share full article 205 205 Advertisement SKIP ADVERTISEMENT You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load. Opinion Supported by SKIP ADVERTISEMENT Guest Essay It’s Code Red for Vaccines June 11, 2025, 5:03 a.m.
Drug Patent Watch
JUNE 9, 2025
"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex. With new laws and guidelines emerging regularly, companies must stay agile to avoid costly delays and maintain market competitiveness.
STAT
JUNE 9, 2025
Health secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the Centers for Disease Control and Prevention, saying the action is needed to restore faith in vaccines. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in an op-ed published Monday afternoon in the Wall Street Journal.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharma Times
JUNE 12, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Levicept presents new LEVI-04 data at EULAR by John Pinching | 12th Jun 2025 | News Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025).
pharmaphorum
JUNE 12, 2025
Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI.
Express Pharma
JUNE 11, 2025
Scientific discovery has always relied on good, clean data. Bad data leads to ir- reproducible outcomes, prob- lematic solutions, and, ultimately, the need to revisit and acquire better data. Now that AI-driven predictive models are becoming more commonplace in early drug discovery workflows, the importance of data that is ac- curate and consistent across en- tire research workflows has never been greater.
STAT
JUNE 12, 2025
As an adoptee who was placed in foster care at 18 months old, I’ve never known my full racial heritage, family tree, or medical history. People have often suggested I try 23andMe or a similar company to get more information on my genetics. But I’ve always felt uneasy about it. So, I felt a little vindicated when I saw the news that Regeneron Pharmaceuticals is set to acquire 23andMe , including its troves of customer data, for $256 million.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharma Times
JUNE 11, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Argenx presents new efgartigimod data at EULAR 2025 by John Pinching | 11th Jun 2025 | News Rheumatology studies show promising results for Sjogren’s disease Argenx has presented positive phase 2 results for efgartigimod in myositis and Sjogren’s disease at EULAR 2025.
pharmaphorum
JUNE 12, 2025
Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.
Pharmacy Joe
JUNE 11, 2025
In this episode, I’ll discuss things a pharmacist should keep in mind when managing a patient with a caustic ingestion. Episode 1034: Pharmacy Considerations When Managing Caustic Ingestion Subscribe on iTunes , Android , or Stitcher According to an article in Intensive Care Medicine, caustic or corrosive ingestion in adult patients is a rare but potentially life-threatening condition with a mortality of 10% among intensive care unit (ICU) patients.
Expert insights. Personalized for you.
52 
Let's personalize your content